NCT01815645

Brief Summary

Crack addiction has become a severe health problem in Brazil. Today, crack addiction is the primary cause for inpatient treatment for all illicit substances. When compared to cocaine, crack users develop much faster diagnoses for crack dependence, shows a more compulsive pattern of use, has higher probability of living or have lived in the streets, and of engaging in illegal activities. Consequently to this, mortality of crack addicts is 7 times higher than for the rest of the population. Despite all efforts being made for the development of effective pharmacological treatments for stimulant addiction (crack included), up to today, there is no robust evidence of efficacy of any pharmacological treatment. For that reason, the use of evidence based psychosocial interventions is so important for treating this population. Although today open treatment facilities in Brazil are more and more starting to use evidence-based interventions such as motivational interviewing, cognitive behavior therapy, relapse prevention and coping skills, such treatments present very modest results when treating crack addiction. The biggest difficulties encountered when treating this population are maintaining patients in treatment, reducing crack use and achieving continued abstinence. A psychosocial treatment based in behavioral principals' named Contingency Management (CM) is widely applied in the USA. Recent meta-analyses and review studies present robust evidence that, when applied alone or in adjunction with other psychosocial and pharmacological treatment, CM is the most effective treatment for what regards, treatment retention, reducing drug use and promoting continued abstinence. The purpose of this study is to evaluate if Contingence Management (CM) can be affective in the treatment of crack addiction in Brazil. To accomplish this, 60 individuals (male and female from 18 to 65 years of age) seeking open treatment for crack addiction will be randomized to 2 treatment conditions (Standard treatment (ST) or ST+CM. Both treatments will last 12 weeks with 3 and 6-month follow-up. In both groups patients will be encourage to leave urine samples 3 times week. Hypotheses: Patients receiving ST+CM will stay longer in treatment, have more negative tests for cocaine/crack, and achieve longer periods of cocaine/crack abstinence when compared to patients receiving ST alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

March 18, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 21, 2013

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

June 19, 2017

Completed
Last Updated

July 27, 2017

Status Verified

July 1, 2017

Enrollment Period

3.1 years

First QC Date

March 18, 2013

Results QC Date

August 10, 2015

Last Update Submit

July 26, 2017

Conditions

Keywords

Cocaine related disordersContingency Managementpsychosocial treatment

Outcome Measures

Primary Outcomes (4)

  • Longest Duaration of Achieved Abstinance

    Number of Participants with 4, 8 and 12 Weeks Continued Abstinence

    12 weeks of treatment

  • Percentage Samples Submitted Negative for Crack Cocaine Use

    Proportion of samples testing negative for Crack Cocaine use

    12 weeks

  • Number of Participants Completing 4, 8 and 12 Weeks of Treatment

    Retention in treatment was quantified as the period elapsed between treatment intake and dropout (last appearance at the treatment facility) or the end of treatment. We present data on the number of participants retained in treatment in weeks 4, 8 and 12.

    Number of participant retained in treatment at weeks 4, 8 and 12.

  • Treatment Attendance

    Treatment attendance was expressed as the total number of sessions attended during the 12 weeks of treatment.

    12 weeks

Secondary Outcomes (2)

  • Percentage Samples Submitted Negative for Alcohol Use

    12 weeks

  • Percentage Samples Submitted Negative for Marihuana Use

    12 weeks

Study Arms (2)

Standard treatment Alone

ACTIVE COMPARATOR

Participants in the Standard Treatment Alone group will receive 12 weeks of the exact treatment provided by the Ambulatory service where the study is being conducted

Behavioral: standard treatment

ST+CM

EXPERIMENTAL

Participants in the Standard treatment plus Contingency Management (ST+CM) group will receive 12 weeks of the exact treatment provided by the Ambulatory service where the study is being conducted plus CM.

Behavioral: ST+CM

Interventions

ST+CMBEHAVIORAL

12 weeks of the standard treatment offered by a open treatment service for drug addiction of the city of Sao Paulo (AME) plus Contingency Management

ST+CM

12 weeks of standard treatment offered by AME (a open treatment service for drug addiction of the city of Sao Paulo)

Standard treatment Alone

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Current diagnose of crack addiction (DSM IV)
  • having used crack in the last month

You may not qualify if:

  • Current psychotic disorder
  • Diagnose of schizophrenia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ambulatorio Medico de Especialidades (AME) da Vila Maria

São Paulo, São Paulo, Brazil

Location

Related Publications (3)

  • Miguel AQ, Madruga CS, Cogo-Moreira H, Yamauchi R, Simoes V, da Silva CJ, McPherson S, Roll JM, Laranjeira RR. Contingency management is effective in promoting abstinence and retention in treatment among crack cocaine users in Brazil: A randomized controlled trial. Psychol Addict Behav. 2016 Aug;30(5):536-543. doi: 10.1037/adb0000192. Epub 2016 Jul 21.

    PMID: 27442691BACKGROUND
  • de Queiroz Constantino Miguel A, Sandi Madruga C, Simoes V, Yamauchi R, da Silva CJ, McDonell M, McPherson S, Roll J, Laranjeira RR, de Jesus Mari J. Contingency management is effective in promoting abstinence and retention in treatment among crack cocaine users with a previous history of poor treatment response: a crossover trial. Psicol Reflex Crit. 2019 Jul 15;32(1):14. doi: 10.1186/s41155-019-0127-2.

  • Miguel AQC, Madruga CS, Cogo-Moreira H, Yamauchi R, Simoes V, Ribeiro A, da Silva CJ, Fruci A, McDonell M, McPherson S, Roll JM, Laranjeira RR. Contingency management targeting abstinence is effective in reducing depressive and anxiety symptoms among crack cocaine-dependent individuals. Exp Clin Psychopharmacol. 2017 Dec;25(6):466-472. doi: 10.1037/pha0000147.

MeSH Terms

Conditions

Cocaine-Related Disorders

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Results Point of Contact

Title
Andre Q. C. Miguel
Organization
Federal University of Sao Paulo

Study Officials

  • Ronaldo R Laranjeira, PhD

    EPM/UNIFESP

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Both participants and researchers know the treatment alocations
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph.D Studant

Study Record Dates

First Submitted

March 18, 2013

First Posted

March 21, 2013

Study Start

May 1, 2012

Primary Completion

June 1, 2015

Study Completion

June 1, 2015

Last Updated

July 27, 2017

Results First Posted

June 19, 2017

Record last verified: 2017-07

Data Sharing

IPD Sharing
Will not share

Locations